Welcome to the first participants of the GSK TRPV4 Study, June 2018

Professor Lorcan McGarvey, Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast, is conducting a new respiratory research study at the NICRF:
"GSK TRPV4: A placebo-controlled, double-blind (sponsor open), randomised, crossover study to assess the efficacy, safety, and tolerability of GSK2798745 in participants with chronic cough"
Read more about the study here.
Share
Latest News
- Support the COVID Rehabilitation Fund23 April, 2020
- Job Opportunity, NICRF: Band 6, BHSCT post2 January, 2020
- Happy New Year from NICRF2 January, 2020
- Welcome to the first participants of the VR_LV Study, November 201811 December, 2018
- Welcome to the first participants of the MACUSTAR Study, January 20194 December, 2018